COMMUNIQUÉS West-GlobeNewswire

Teladoc Health to Host Investor Day on September 27, 2018

13/09/2018 - 14:35

PURCHASE, NY, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in virtual care, announced today that it will host its Investor Day on Thursday, September 27, 2018, in New York [...]

Todos Medical, Ltd. Signs Non-Binding Memorandum of Understanding with Orot+ for Distribution Rights of its Breast Cancer Screening Tests in Romania and Austria

13/09/2018 - 14:30

REHOVOT, Israel, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer, today [...]

Advanced Proteome Therapeutics Announces Progress on Antibody-Radioisotope Conjugate Initiative

13/09/2018 - 14:30

VANCOUVER, British Columbia, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8) , is pleased to report significant progress in applying the [...]

Assure Holdings Performs First Neuromonitoring Case in Pennsylvania

13/09/2018 - 14:30

Marks Assure’s Expansion into its Fifth State DENVER, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services [...]

VistaGen Therapeutics Acquires Worldwide License of Phase 3-Ready CNS Drug Candidate from Pherin Pharmaceuticals for As-Needed Treatment of Social Anxiety Disorder

13/09/2018 - 14:30

Phase 3-ready asset expands VistaGen’s CNS pipeline and complements its neuropsychiatry focus on Major Depressive Disorder (MDD) with AV-101 Novel PH94B nasal spray expected to enter pivotal Phase 3 development for as- [...]

SELLAS Receives Orphan Medicinal Product Designation Approval by the Committee for Orphan Medicinal Products of the European Medicines Agency for Galinpepimut-S for the Treatment of Patients with Multiple Myeloma

13/09/2018 - 14:30

NEW YORK, Sept. 13, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq:SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer [...]

Viveve Appoints Two New Independent Board Members

13/09/2018 - 14:28

ENGLEWOOD, Colo., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today announced that Steve Basta and Karen Zaderej have joined [...]

Cannabco Announces That Proposed Reverse Takeover Will Not Proceed

13/09/2018 - 14:25

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, Sept. 13, 2018 (GLOBE NEWSWIRE) -- [...]

EPSi announces partnership with MPA Healthcare Solutions

13/09/2018 - 14:01

New Performance Analytics for Risk-based Contracts and Medicare Payments to extend EPSi Platform Capabilities CHICAGO, Sept. 13, 2018 (GLOBE NEWSWIRE) -- EPSi, Allscripts (NASDAQ: MDRX) flagship budgeting, long-range [...]

CARsgen Therapeutics and CrownBio complete CAR-T study for gastric cancer

13/09/2018 - 14:00

Claudin18.2 specific CAR-T cells show tumor elimination in PDX models SAN DIEGO, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational [...]

HealthEC Helps ACO Partners Generate $21.4 Million in Medicare Shared Savings for 2017 Performance Year

13/09/2018 - 14:00

Firm achieves 100% client success rate and helps return more than $9.5 million to customers EDISON, N.J., Sept. 13, 2018 (GLOBE NEWSWIRE) -- HealthEC , a KLAS-recognized end-to-end provider of Population Health [...]

Health Canada Reclassifies Tetra Bio-Pharma’s Inhalation Device Making it Eligible for Reimbursement

13/09/2018 - 14:00

ORLEANS, Ontario, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc . (" Tetra " or the " Corporation ") (TSX VENTURE: TBP) (OTCQB: TBPMF), a global leader in cannabinoid-based drug development and discovery, [...]

IBEX Reports Operational Management Changes

13/09/2018 - 14:00

MONTREAL, Sept. 13, 2018 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported changes in its operating management ranks. After 25 years of dedicated service Catherine [...]

Delcath Reminds Shareholders that the Rights Offering Subscription Period Expires Wednesday, September 26, 2018

13/09/2018 - 14:00

NEW YORK, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, reminds its shareholders of the [...]

Data From Clearside Biomedical’s Pivotal Phase 3 PEACHTREE Clinical Trial in Macular Edema Associated with Non-Infectious Uveitis to be Presented at the Retina Society 51st Annual Scientific Meeting

13/09/2018 - 14:00

ALPHARETTA, Ga., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]

XBiotech Announces Completion and Positive Interim Findings for Initial Cohort in Bermekimab Pilot Study in Atopic Dermatitis

13/09/2018 - 14:00

Company Reports Positive Safety Outcome and Statistically Significant Improvements in Atopic Dermatitis Patients Treated with Low Dose, Short Course of Bermekimab AUSTIN, Texas, Sept. 13, 2018 (GLOBE NEWSWIRE) -- [...]

Large-Scale Global Genome Projects Choose PacBio Sequencing to Help Decode Life

13/09/2018 - 14:00

High-quality reference genomes for thousands of plant, animal and microbial species to be created using SMRT Sequencing MENLO PARK, Calif., Sept. 13, 2018 (GLOBE NEWSWIRE) -- When creating a genomic ark of creatures [...]

Verona Pharma to Host Conference Call to Review Expanded Dataset from RPL554 Phase 2b Clinical Trial in COPD Presented at European Respiratory Society International Congress

13/09/2018 - 14:00

LONDON, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]

Solid Biosciences Welcomes Sukumar Nagendran, M.D., To Its Board Of Directors

13/09/2018 - 13:30

CAMBRIDGE, Mass., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ: SLDB) today announced that Sukumar Nagendran, M.D., has been elected to its Board of Directors. Dr. Nagendran brings to Solid more [...]